Viemed Healthcare (VMD) Competitors $8.80 +0.26 (+3.04%) (As of 09:35 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VMD vs. ARA, PGNY, AHCO, CDNA, AVAH, PNTG, CSTL, AGL, INNV, and SHCRShould you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include American Renal Associates (ARA), Progyny (PGNY), AdaptHealth (AHCO), CareDx (CDNA), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Castle Biosciences (CSTL), agilon health (AGL), InnovAge (INNV), and Sharecare (SHCR). These companies are all part of the "medical" sector. Viemed Healthcare vs. American Renal Associates Progyny AdaptHealth CareDx Aveanna Healthcare The Pennant Group Castle Biosciences agilon health InnovAge Sharecare Viemed Healthcare (NASDAQ:VMD) and American Renal Associates (NYSE:ARA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, community ranking, institutional ownership, profitability, valuation, analyst recommendations and media sentiment. Which has stronger valuation and earnings, VMD or ARA? Viemed Healthcare has higher earnings, but lower revenue than American Renal Associates. Viemed Healthcare is trading at a lower price-to-earnings ratio than American Renal Associates, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViemed Healthcare$183.01M1.82$10.24M$0.2731.63American Renal Associates$822.52M0.48-$13.79M$0.2644.31 Is VMD or ARA more profitable? Viemed Healthcare has a net margin of 4.87% compared to American Renal Associates' net margin of -2.04%. Viemed Healthcare's return on equity of 8.72% beat American Renal Associates' return on equity.Company Net Margins Return on Equity Return on Assets Viemed Healthcare4.87% 8.72% 6.48% American Renal Associates -2.04%-3.56%-0.24% Do institutionals & insiders have more ownership in VMD or ARA? 74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 78.4% of American Renal Associates shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 9.5% of American Renal Associates shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer VMD or ARA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00American Renal Associates 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in VMD or ARA? American Renal Associates received 204 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 62.73% of users gave American Renal Associates an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote. CompanyUnderperformOutperformViemed HealthcareOutperform Votes342.86% Underperform Votes457.14% American Renal AssociatesOutperform Votes20762.73% Underperform Votes12337.27% Does the media prefer VMD or ARA? In the previous week, Viemed Healthcare had 5 more articles in the media than American Renal Associates. MarketBeat recorded 5 mentions for Viemed Healthcare and 0 mentions for American Renal Associates. Viemed Healthcare's average media sentiment score of 0.38 beat American Renal Associates' score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Overall Sentiment Viemed Healthcare Neutral American Renal Associates Neutral Which has more risk and volatility, VMD or ARA? Viemed Healthcare has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, American Renal Associates has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. SummaryViemed Healthcare beats American Renal Associates on 13 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Viemed Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VMD vs. The Competition Export to ExcelMetricViemed Healthcarehealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$332.55M$2.02B$5.06B$8.82BDividend YieldN/A6.93%5.18%4.07%P/E Ratio31.6315.77126.3217.81Price / Sales1.825.761,179.2574.56Price / Cash10.2411.3633.8632.53Price / Book2.623.274.684.68Net Income$10.24M$69.56M$119.54M$226.08M7 Day Performance-5.74%-0.74%-1.83%-1.04%1 Month Performance-7.38%3.92%-3.60%1.04%1 Year Performance9.21%-18.29%31.91%26.28% Viemed Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VMDViemed Healthcare1.8847 of 5 stars$8.80+3.0%N/A+10.9%$342.67M$183.01M32.59630ARAAmerican Renal AssociatesN/A$11.52flatN/A+0.0%$397.94M$822.52M44.314,977PGNYProgyny3.6189 of 5 stars$13.99+0.1%$25.42+81.7%-57.8%$1.19B$1.09B24.10563AHCOAdaptHealth2.8439 of 5 stars$9.73+0.1%$11.67+19.9%+14.1%$1.31B$3.20B0.0010,700Analyst ForecastCDNACareDx3.9032 of 5 stars$22.52+0.7%$29.60+31.4%+131.1%$1.21B$280.32M0.00740AVAHAveanna Healthcare0.4931 of 5 stars$5.88+1.9%$4.27-27.4%+162.3%$1.14B$1.90B0.0033,500PNTGThe Pennant Group3.6146 of 5 stars$30.49-0.9%$38.25+25.5%+126.2%$1.05B$544.89M45.275,791CSTLCastle Biosciences3.472 of 5 stars$28.45-1.5%$37.88+33.1%+41.8%$796.88M$219.79M142.26540Insider TradeAGLagilon health2.2561 of 5 stars$1.66-0.6%$6.05+264.5%-85.4%$683.95M$4.32B0.001,117Analyst ForecastINNVInnovAge1.4851 of 5 stars$4.76+1.3%$6.50+36.6%-19.0%$644.79M$763.85M0.002,350SHCRSharecareN/A$1.43flat$1.43N/A$531.79M$445.25M-3.673,352 Related Companies and Tools Related Companies ARA Competitors PGNY Competitors AHCO Competitors CDNA Competitors AVAH Competitors PNTG Competitors CSTL Competitors AGL Competitors INNV Competitors SHCR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viemed Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viemed Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
